03.03.15
Pierre Fabre Groupn and Abbott Healthcare Pvt. Ltd., one of India's largest pharmaceutical & healthcare companies, have renewed their partnership. Pierre Fabre Group says it is the 3rd largest French pharmaceutical group and the 2nd largest dermo‐cosmetics laboratory in the world.
The two companies will market 3 unique dermo-cosmetic ranges in India - Avene, Ducray, and A-Derma.
Sudarshan Jain, Managing Director of Abbott Healthcare, commented:
"Abbott's partnership with Pierre Fabre shows our commitment to bring to India globally renowned derma-cosmetic formulations. These globally popular brands addresses multitudes of skin concerns of people with sensitive skin or irritated skin; and preserving health and beauty of normal skin and hair.”
M. Eric Ducournau, Chairman Pierre Fabre Dermo-Cosmetics, added:
"Pierre Fabre's background as a pharmaceutical company specializing in Dermatology in addition with its French know-how of cosmetic formulation is today perfectly completed with a high knowledge of the Indian market through our association with Abbott. In order to fulfil the highest expectations of sensitive or fragile skins, clinical and consumer tests have been performed internationally but also locally to show efficiency and acceptation of our formulations on Indian skin.”
The two companies will market 3 unique dermo-cosmetic ranges in India - Avene, Ducray, and A-Derma.
Sudarshan Jain, Managing Director of Abbott Healthcare, commented:
"Abbott's partnership with Pierre Fabre shows our commitment to bring to India globally renowned derma-cosmetic formulations. These globally popular brands addresses multitudes of skin concerns of people with sensitive skin or irritated skin; and preserving health and beauty of normal skin and hair.”
M. Eric Ducournau, Chairman Pierre Fabre Dermo-Cosmetics, added:
"Pierre Fabre's background as a pharmaceutical company specializing in Dermatology in addition with its French know-how of cosmetic formulation is today perfectly completed with a high knowledge of the Indian market through our association with Abbott. In order to fulfil the highest expectations of sensitive or fragile skins, clinical and consumer tests have been performed internationally but also locally to show efficiency and acceptation of our formulations on Indian skin.”